December 15, 2024 09:46 (IST)
Remdesivir drug helps moderately ill COVID-19 patients, says Gilead
Jun 02, 2020, at 08:33 am
California: California-based biotech company Gilead Sciences, Inc on Monday announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia.
Latest Headlines
Remdesivir drug helps moderately ill COVID-19 patients, says Gilead
Tue, Jun 02 2020